Skip to main content
Fig. 5 | Head & Face Medicine

Fig. 5

From: The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway

Fig. 5

ACC-83 cells were incubated with both the Nrf2 inhibitor ML385 and MG132 for 12 h to observe the proliferation and apoptosis. A Cell viability was determined by CCK8 assay (mean ± SD). All data were obtained from three independent experiments performed in triplicate. B Cells were treated with MG132 in 0µM, 10µM, 40µM and 70µM for 12 h. C Cells were treated with both ML385 and MG132, the data was measured by flow cytometry. The apoptosis of the group incubated with MG132 was higher than the group incubated with both ML385 and MG132. *P < 0.05,**P < 0.01 versus group treated with MG132

Back to article page